EML 425 is a small molecule inhibitor that potently and selectively targets the CBP and p300 bromodomains, with respective IC50 values of 2.9 µM and 1.1 µM. This compound is a valuable chemical probe for epigenetic research, used in vitro to investigate the roles of these transcriptional coactivators in cancer and cellular differentiation pathways.